Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, B-Cell × avelumab × 90 days × Clear all

Sponsor

Conditions

Urinary Bladder Neoplasms 8 Carcinoma, Transitional Cell 8 Carcinoma, Renal Cell 5 Carcinoma, Merkel Cell 5 Neoplasms 4 Stomach Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 3 Neoplasm Metastasis 3 Melanoma 3 Carcinoma, Non-Small-Cell Lung 3 Uterine Cervical Neoplasms 2 Urethral Neoplasms 2 Ureteral Neoplasms 2 Triple Negative Breast Neoplasms 2 Small Cell Lung Carcinoma 2 Skin Neoplasms 2 Carcinoma, Hepatocellular 2 Breast Neoplasms 2 Turcot syndrome 1 Thymoma 1 Sarcoma 1 Prostatic Neoplasms 1 Peritoneal Neoplasms 1 Penile Squamous Cell Carcinoma (PSCC) 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Ovarian Neoplasms 1 Osteosarcoma 1 Motor Activity 1 Microsatellite Instability 1 Metastatic Urothelial Cancer 1

Interventions

Cyclophosphamide 16 Rituximab 13 fludarabine 10 pirtobrutinib 7 Specimen Handling 7 Magnetic Resonance Spectroscopy 7 glofitamab 5 Doxorubicin 5 venetoclax 4 fludarabine phosphate 4 Vincristine 4 Prednisone 4 Leukapheresis 4 Biopsy 4 zanubrutinib 3 polatuzumab vedotin 3 pembrolizumab 3 obinutuzumab 3 Lenalidomide 3 Etoposide 3 Dexamethasone 3 Bendamustine Hydrochloride 3 tazemetostat 2 tafasitamab 2 axicabtagene ciloleucel 2 acalabrutinib 2 Gemcitabine 2 Cytarabine 2 Cisplatin 2 Calcium Dobesilate 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡